Sökresultat - Donald Poon

  • Visas 1 - 5 av 5 resultat
Förfina resultatet
  1. 1
    Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer

    Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer av Qingyu Zhou, Alex Sparreboom, Eng‐Huat Tan, Yin‐Bun Cheung, Ann Lee, Donald Poon, Edmund J.D. Lee, Balram Chowbay

    Publicerad 2005
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma

    RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma av Hung Huynh, Pierce K. H. Chow, Khee Chee Soo, Han Chong Toh, Su Pin Choo, Kian Fong Foo, Donald Poon, Van Chanh Ngo, Evelyn Tran

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma av Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Donald Poon, Su Pin Choo, Choon Hua Thng, Pierce K. H. Chow, Hock Soo Ong, Alexander Yaw Fui Chung, Khee Chee Soo

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma

    Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma av Pierce K. H. Chow, Donald Poon, Khin Maung Win, Harjit Singh, Ho‐Seong Han, Anthony Goh, Su Pin Choo, Hee-Kit Lai, Richard Hoau Gong Lo, Kiang‐Hiong Tay, T.W. Lim, Mihir Gandhi, Say‐Beng Tan, Khee‐Chee Soo

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues

    Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues av Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Thomas Walter, Christos Toumpanakis, Michael A. Morse, Paola Tomassetti, Matthias M. Weber, David R. Fogelman, John Ramage, Donald Poon, Brian Gadbaw, Li Jiang, Janice L. Pasieka, Abakar Mahamat, Fredrik Swahn, John Newell‐Price, Wasat Mansoor, Kjell Öberg

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: